Veterinary Medicines

CARBESIA SOLUTION INJECTABLE POUR BOVINS ET CHIENS

Authorised
  • Imidocarb dipropionate
Download as PDF

Product identification

Medicine name:
CARBESIA SOLUTION INJECTABLE POUR BOVINS ET CHIENS
Active substance:
  • Imidocarb dipropionate
Target species:
  • Cattle
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Imidocarb dipropionate
    121.15
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        213
        day
      • Milk
        6
        day
    • Dog
  • Subcutaneous use
    • Cattle
      • Meat and offal
        213
        day
      • Milk
        6
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51EX01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vet Pharma Friesoythe GmbH
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/6280218 7/1980
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 23/12/2024
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 23/12/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."